Gentium S.p.a. Asset Turnover Ratio (GENT), as of fourth quarter 2013, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Gentium S.p.a.  (GENT)
 

Gentium S.p.a. Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Gentium S.p.a. asset turnover ratio, the ability of Gentium S.p.a.'s assets to generate revenue in the fourth quarter 2013, increased sequentially to 1.21 in the fourth quarter (Dec 31 2013), GENT's balance sheet remain strong.

Within sector 7 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2013 compared to the preceding quarter from 0 to 2390.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

GENT Asset Turnover Ratio (Dec 31 2013)
IV. Quarter		 0
III. Quarter		 (Jun 30 2013)
II. Quarter		 0
I. Quarter		 (Dec 31 2012)
FY
Y / Y Asset Change 99.1 % -38.47 % -31.71 % 59.68 % -
Y / Y Revenue Change 52.64 % - -59.82 % - -
Asset Turnover Ratio (TTM) 1.21 - 1.27 - 1.8
GENT's Total Ranking # 2390 # 0 # 0 # 0 # 0
Seq. Asset Change 247.77 % -22.92 % 29.73 % -42.75 % 7.48 %
Seq. Revenue Change - - - - 241.77 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 8
Healthcare Sector # 198
Overall Market # 2390

Asset Turnover Ratio Statistics
High Average Low
0.99 0.81 0.63
(Dec 31 2012)   (Dec 31 2013)




GENT Company Profile • Back to GENT Efficiency Comparisons • Compare GENT Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2013, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2013 Assets at quarter ending Dec 31 2013
Cryo cell International Inc   1.62 $ 18.995  Millions$ 11.746  Millions
Enzo Biochem Inc  1.61 $ 92.929  Millions$ 57.652  Millions
Milestone Scientific Inc   1.60 $ 10.372  Millions$ 6.468  Millions
Lhc Group Inc   1.60 $ 658.283  Millions$ 411.638  Millions
Livewire Ergogenics Inc.  1.59 $ 0.146  Millions$ 0.092  Millions
Escalon Medical Corp   1.59 $ 11.795  Millions$ 7.409  Millions
Chemed Corporation  1.58 $ 1,413.329  Millions$ 893.382  Millions
Adicet Bio Inc   1.56 $ 519.755  Millions$ 332.434  Millions
Genomic Health Inc  1.54 $ 261.594  Millions$ 169.598  Millions
Prophase Labs Inc   1.53 $ 25.032  Millions$ 16.323  Millions
Teligent Inc   1.48 $ 18.224  Millions$ 12.319  Millions
Shattuck Labs Inc   1.48 $ 1.769  Millions$ 1.197  Millions
Dexcom Inc   1.48 $ 160.000  Millions$ 108.425  Millions
Koru Medical Systems Inc   1.47 $ 8.062  Millions$ 5.466  Millions
Yunhong Green Cti Ltd   1.47 $ 56.059  Millions$ 38.113  Millions
Heartbeam Inc   1.45 $ 129.501  Millions$ 89.044  Millions
Precision Optics Corporation Inc   1.45 $ 3.373  Millions$ 2.322  Millions
Therapeutic Solutions International Inc   1.44 $ 0.312  Millions$ 0.216  Millions
Abeona Therapeutics Inc   1.40 $ 2.042  Millions$ 1.456  Millions
United Cannabis Corp  1.40 $ 0.106  Millions$ 0.075  Millions
Camp4 Therapeutics Corporation  1.40 $ 224.447  Millions$ 160.584  Millions
U S Physical Therapy Inc  1.39 $ 264.756  Millions$ 190.775  Millions
Patterson Companies Inc   1.38 $ 3,926.571  Millions$ 2,842.218  Millions
Rockwell Medical inc   1.38 $ 52.380  Millions$ 37.990  Millions
Ufp Technologies Inc   1.36 $ 139.222  Millions$ 102.588  Millions
Ipc Healthcare, Inc.  1.35 $ 609.517  Millions$ 451.891  Millions
Sanara Medtech Inc   1.34 $ 1.726  Millions$ 1.288  Millions
Stereotaxis Inc   1.34 $ 38.031  Millions$ 28.415  Millions
Masimo Corp  1.33 $ 547.246  Millions$ 412.872  Millions
Micron Solutions Inc  1.32 $ 21.341  Millions$ 16.129  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.